Literature DB >> 11421530

A cluster of cases of factitious Cushing's syndrome.

R B Villanueva1, E Brett, J L Gabrilove.   

Abstract

OBJECTIVE: To review the patient profiles, laboratory data, and diagnostic approaches in factitious administration of glucocorticoids.
METHODS: Four cases of surreptitious use of glucocorticoids are presented. Clinical and laboratory data as well as imaging studies are summarized. Pertinent case reports in the literature are reviewed.
RESULTS: We report four cases of surreptitious use of glucocorticoids encountered within a 2-year period. All four patients were women without significant psychiatric histories. In three patients, the question of factitious Cushing's syndrome was suspected because of physical evidence or symptoms of Cushing's syndrome (or both) in the setting of suppressed cortisol levels. The fourth patient had undetectable cortisol levels in both serum and 24-hour urine samples but did not have signs or symptoms of adrenal insufficiency. In three cases, the diagnosis was confirmed by direct measurement of synthetic glucocorticoids in the patient's urine or serum. The fourth case was diagnosed by correlating increased cortisol levels with decreased precursor adrenal steroids.
CONCLUSIONS: Exogenous corticosteroid use in the absence of a medical indication poses a serious risk to a patient. This possibility should be considered in patients with signs and symptoms consistent with Cushing's syndrome but with low serum and urinary cortisol levels. Similarly, this diagnosis should be suggested in patients without symptoms of adrenal insufficiency and with low cortisol levels. Laboratory measurement of synthetic steroids can be helpful in confirming the diagnosis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11421530     DOI: 10.4158/EP.6.2.143

Source DB:  PubMed          Journal:  Endocr Pract        ISSN: 1530-891X            Impact factor:   3.443


  4 in total

1.  Cushing's syndrome secondary to isolated micronodular adrenocortical disease (iMAD) associated with rapid onset weight gain and negative abdominal MRI findings in a 3 year old male.

Authors:  Rohan K Henry; Margaret F Keil; Constantine A Stratakis; Patricia Y Fechner
Journal:  J Pediatr Endocrinol Metab       Date:  2010-06       Impact factor: 1.634

2.  Hypertension and other morbidities with Cushing's syndrome associated with corticosteroids: a review.

Authors:  Melpomeni Peppa; Maria Krania; Sotirios A Raptis
Journal:  Integr Blood Press Control       Date:  2011-03-03

3.  RETRACTED ARTICLE: Fatal factitious Cushing syndrome (Münchhausen's syndrome) in a patient with macroprolactinoma and silent corticotrophinoma: case report and literature review.

Authors:  Carlos André Minanni; Ana Luiza De Almeida Cardoso; Edoarda Vasco de Albuquerque Albuquerque; Luciana Pinto Brito; Ludmilla Malveira Lima Lopes; Andrea Glezer; Elisa Del Rosario Ugarte Verduguez; Berenice Bilharinho De Mendonça; Marcello Delano Bronstein; Marcio Carlos Machado; Maria Candida Barisson Villares Fragoso
Journal:  Clin Diabetes Endocrinol       Date:  2015-06-04

4.  Factitious Cushing's syndrome, hypopituitarism, and self-provoked skin lesions: when the skin mirrors the soul.

Authors:  Salvatore Cannavò; Serafinella Patrizia Cannavò
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2021-08-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.